《日本胃癌治疗指南2014（第4版）》 - Suppr

Suppr

超能文献

Japanese gastric cancer treatment guidelines 2014 (ver. 4).

出版信息

Gastric Cancer. 2017 Jan;20(1):1-19. doi: 10.1007/s10120-016-0622-4. Epub 2016 Jun 24.

DOI:10.1007/s10120-016-0622-4

PMID:27342689

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5215069/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb1/5215069/a225d7acc4db/10120_2016_622_Fig1_HTML.jpg

相似文献

Japanese gastric cancer treatment guidelines 2014 (ver. 4).

Gastric Cancer. 2017 Jan;20(1):1-19. doi: 10.1007/s10120-016-0622-4. Epub 2016 Jun 24.

Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Gastric Cancer. 2011 Jun;14(2):113-23. doi: 10.1007/s10120-011-0042-4.

[Evaluation of the gastric cancer treatment guidelines of the Japanese Gastric Cancer Association].

Gan To Kagaku Ryoho. 2010 Apr;37(4):582-6.

Gastric cancer treatment guidelines in Japan.

Gastric Cancer. 2002;5(1):1-5. doi: 10.1007/s101200200000.

[In regard to gastric cancer treatment guidelines--a revised edition].

Gan To Kagaku Ryoho. 2004 Nov;31(12):1947-51.

Improving treatment outcome for gastric cancer: the role of surgery and adjuvant therapy.

J Clin Oncol. 2003 Dec 1;21(23 Suppl):272s-273s. doi: 10.1200/JCO.2003.09.136.

[Some light for the prognosis of gastric cancer].

Duodecim. 2001;117(18):1785-7.

[Differences between Japan and the west in treatment strategy for gastrointestinal cancer--gastric cancer].

Gan To Kagaku Ryoho. 1998 Jul;25(8):1118-22.

The gastric cancer treatment controversy.

J Clin Oncol. 2003 Jun 15;21(12):2234-6. doi: 10.1200/JCO.2003.91.138.

Immunotherapy as adjuvant treatment after curative resection of gastric cancer.

Lancet. 1994 Jul 23;344(8917):274. doi: 10.1016/s0140-6736(94)93042-2.

引用本文的文献

Comparison of short- and long-term outcomes among total laparoscopic, laparoscopic-assisted, and open total gastrectomies for advanced gastric cancer patients after neoadjuvant chemotherapy: a multicenter retrospective cohort study.

BMC Cancer. 2025 Aug 30;25(1):1401. doi: 10.1186/s12885-025-14765-x.

Long-term oncological outcomes of indocyanine green fluorescence imaging-guided laparoscopic lymphadenectomy for gastric cancer: 5-year outcomes from the FUGES-012 randomized clinical trial.

BMC Med. 2025 Aug 26;23(1):497. doi: 10.1186/s12916-025-04334-1.

Early application of nanocarbon suspension in gastric cancer patients enhances postoperative lymph node detection.

World J Surg Oncol. 2025 Aug 22;23(1):316. doi: 10.1186/s12957-025-03972-2.

Effects of Rikkunshito on postgastrectomy weight loss and nutritional status in gastric cancer patients: A retrospective observational study.

Medicine (Baltimore). 2025 Aug 15;104(33):e43950. doi: 10.1097/MD.0000000000043950.

Siewert II esophagogastric junction cancer: total gastrectomy or esophagectomy?

Arq Bras Cir Dig. 2025 Aug 4;38:e1888. doi: 10.1590/0102-67202025000019e1888. eCollection 2025.

Large metastatic lymph nodes misdiagnosed as a pancreatic tumor: a case report.

J Surg Case Rep. 2025 Aug 1;2025(7):rjaf583. doi: 10.1093/jscr/rjaf583. eCollection 2025 Jul.

The Effect of Extended Dissection of Lymph Nodes (D2plus) with Gastrectomy on the Clinical and Oncological Outcomes in Gastric Cancer Patients, Compared to a Standard Dissection (D2).

Medicina (Kaunas). 2025 Jul 16;61(7):1284. doi: 10.3390/medicina61071284.

Emerging role of circular RNAs in gastric cancer: From basic biology to clinical applications (Review).

Mol Med Rep. 2025 Sep;32(3). doi: 10.3892/mmr.2025.13617. Epub 2025 Jul 11.

Intraoperative corticosteroid administration for resectable gastric cancer: a multicenter, randomized, open-label, phase II/III study.

Gastric Cancer. 2025 Jul 10. doi: 10.1007/s10120-025-01635-5.

Long-term outcomes of S-1 monotherapy in stage IIIA gastric cancer with small tumors and low nodal involvement.

Langenbecks Arch Surg. 2025 Jul 10;410(1):219. doi: 10.1007/s00423-025-03781-x.

本文引用的文献

Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma.

Ann Surg. 2017 Feb;265(2):277-283. doi: 10.1097/SLA.0000000000001814.

Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study.

Gastric Cancer. 2017 Mar;20(2):332-340. doi: 10.1007/s10120-016-0606-4. Epub 2016 Mar 8.

Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.

Lancet Oncol. 2016 Mar;17(3):309-318. doi: 10.1016/S1470-2045(15)00553-7. Epub 2016 Jan 26.

Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy.

Gastric Cancer. 2017 Jan;20(1):175-181. doi: 10.1007/s10120-015-0581-1. Epub 2015 Dec 1.

Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407).

Gastric Cancer. 2016 Jul;19(3):902-10. doi: 10.1007/s10120-015-0542-8. Epub 2015 Sep 19.

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.

Lancet Oncol. 2014 Nov;15(12):1389-96. doi: 10.1016/S1470-2045(14)70473-5. Epub 2014 Oct 15.

Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer.

Ann Oncol. 2015 Jan;26(1):141-148. doi: 10.1093/annonc/mdu472. Epub 2014 Oct 14.

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.

Lancet Oncol. 2014 Oct;15(11):1224-35. doi: 10.1016/S1470-2045(14)70420-6. Epub 2014 Sep 17.

Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.

Br J Surg. 2014 May;101(6):653-60. doi: 10.1002/bjs.9484. Epub 2014 Mar 25.

Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START).

J Cancer Res Clin Oncol. 2014 Feb;140(2):319-28. doi: 10.1007/s00432-013-1563-5. Epub 2013 Dec 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验